BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 17191048)

  • 1. Recurrent erysipelas: 47 cases.
    Leclerc S; Teixeira A; Mahé E; Descamps V; Crickx B; Chosidow O
    Dermatology; 2007; 214(1):52-7. PubMed ID: 17191048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent erysipelas despite antibiotic prophylaxis: an analysis from case studies.
    Koster JB; Kullberg BJ; van der Meer JW
    Neth J Med; 2007 Mar; 65(3):89-94. PubMed ID: 17387234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erysipelas. Retrospective study of 647 patients].
    Zaraa I; Zeglaoui F; Zouari B; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2004 Nov; 82(11):990-5. PubMed ID: 15822466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study.
    Vignes S; Dupuy A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital.
    Lazzarini L; Conti E; Tositti G; de Lalla F
    J Infect; 2005 Dec; 51(5):383-9. PubMed ID: 16321649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up.
    Cox NH
    Br J Dermatol; 2006 Nov; 155(5):947-50. PubMed ID: 17034523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erysipelas: epidemiological, clinical and therapeutic data (111 cases)].
    Crickx B; Chevron F; Sigal-Nahum M; Bilet S; Faucher F; Picard C; Lazareth I; Belaich S
    Ann Dermatol Venereol; 1991; 118(1):11-6. PubMed ID: 2018300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erysipelas in the young population of a military hospital].
    Mahé E; Toussaint P; Lamarque D; Boutchnei S; Guiguen Y
    Ann Dermatol Venereol; 1999; 126(8-9):593-9. PubMed ID: 10530346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erysipelas after osteoarticular prosthesis].
    Dhrif AS; El Euch D; Ben Tekaya N; Mokni M; Cherif F; Azaiz MI; Dhahri AB
    Med Mal Infect; 2005 Sep; 35(9):463-5. PubMed ID: 16271839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erysipelas and cellulitis: a retrospective study of 122 cases].
    Concheiro J; Loureiro M; González-Vilas D; García-Gavín J; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2009 Dec; 100(10):888-94. PubMed ID: 20038366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erysipelas after breast cancer treatment].
    Ben Salah H; Siala W; Maaloul I; Bouzid F; Frikha M; Daoud J
    Tunis Med; 2002 Aug; 80(8):465-8. PubMed ID: 12703126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Boukari T; Pitché P; Tchangaï-Walla K
    Med Trop (Mars); 2011 Apr; 71(2):162-4. PubMed ID: 21695874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erysipelas--course of disease, recurrence, complications; a 10 years retrospective study].
    Wojas-Pelc A; Alekseenko A; Jaworek AK
    Przegl Epidemiol; 2007; 61(3):457-64. PubMed ID: 18069381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hip surgery skin cellulitis.
    Mainetti C; Bernard P; Saurat JH
    Eur J Med; 1992 Apr; 1(1):52-4. PubMed ID: 1341978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and comorbidity of erysipelas in primary care.
    Bartholomeeusen S; Vandenbroucke J; Truyers C; Buntinx F
    Dermatology; 2007; 215(2):118-22. PubMed ID: 17684373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic use in patients with erysipelas: a retrospective study.
    Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S
    Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients.
    Rob F; Hercogová J
    J Dermatolog Treat; 2018 Feb; 29(1):39-43. PubMed ID: 28489486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Demographic, clinical and laboratory characteristics of erisypelas in the period 2001-2010].
    Vâţă D; Solovăstru LG; Vâţă A; Dorobăţ C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1042-7. PubMed ID: 22276443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pristinamycin in the treatment of acute bacterial dermohypodermitis in adults. An open study of 42 patients].
    Bernard P; Risse L; Bonnetblanc JM
    Ann Dermatol Venereol; 1996; 123(1):16-20. PubMed ID: 8734110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study.
    Mokni M; Dupuy A; Denguezli M; Dhaoui R; Bouassida S; Amri M; Fenniche S; Zeglaoui F; Doss N; Nouira R; Ben Osman-Dhahri A; Zili J; Mokhtar I; Kamoun MR; Zahaf A; Chosidow O
    Dermatology; 2006; 212(2):108-12. PubMed ID: 16484815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.